0620/24SCR019-18/R10
Media Highlights
From the 2024 ASCO® Annual Meeting
9
Media Outlet Article / Coverage
Onco Daily Vivek Subbiah Receives 2024 Yvonne Award in the Voice of
Oncology Category
PharmaExec.com Illumina Pushes Genomic Sequencing in Oncology at ASCO
VuMedi ASCO® 2024 Precision Medicine Highlights: LAURA and
CROWN Trials (NSCLC), HERKULES-3 Trial (CRC), Novel
Agents in ER+/HER2- BC
Vivek Subbiah, MD,
SCRI
Media Outlet Article / Coverage
Oncology News Central "Back to the Drawing Board" for Taxane-Induced Peripheral
Neuropathy Risk Prediction in Black Women?
OncoZine ASCO 2024: NATALEE shows Ribociclib Reduces Risk of Cancer
Recurrence in Early Breast Cancer
Pharmacy Times NATALEE Data Show Ribociclib Reduces Risk of Recurrence
for High-Risk Node-Negative Early Breast Cancer
The ASCO Post Denise A. Yardley, MD, on Early Breast Cancer: Findings
From the NATALEE Trial on Patients With Node-Negative
Disease
VuMedi ASCO® 2024 Insights: "NATALEE Trial - Baseline
Characteristics and Efficacy Outcomes in N0 HR+/HER2-
eBC"
Denise Yardley, MD
SCRI
